PubMed Health⌕ Search

Biomedical subjects

Heung-Jin Choi

Publications and source records attributed to Heung-Jin Choi.

7 recordsLinked to original sources

Structural properties of benzimidazole cavitand and its selective recognition toward 4-methylbenzamide over 4-methylanilide.

The conformations and properties of cavitand 5 with four benzimidazole flaps are studied by (1)H NMR. The benzimidazole cavitand 5 can form very stable vase structures with an enforced concave cavity by intermolecular hydrogen bonding with four hydroxyl-containing molecules, X-OH, such as methanol (X = Me), acetic acid (X = CH(3)CO), and trifluoroacetic acid (X = CF(3)CO). The stronger hydrogen bond donor strengths of X-OH are, the stronger hydrogen bonds are formed between the NH and N atoms of the neighboring benzimidazole fragments and the more vase structures of 5.4HOX are stable. The annular tautomerism of 5 in CDCl(3)/CD(3)OD (9:1, v/v) due to the proton exchange between NH and N atoms of the neighboring benzimidazole fragments is observed by 400 MHz (1)H NMR, and the free energy of activation is measured as DeltaG++(210) = 10.2 kcal/mol at a coalescence temperature of 210 K. Cavitand 5 forms inclusion complexes with 4-methylbezamide guests such as 4-methyl-N-p-tolylbenzamide 6 and N,4-dimethylbenzamide 7 in water-saturated CDCl(3). However, an isomorphic 4-methylanilide guest such as N-4-tolylacetamide 8 cannot be recognized in the concave cavity of 5. This high selectivity toward 4-methylbenzamide over 4-methylanilide seems attributable to the hydrogen-binding interaction between the NH proton of 4-methylbezamide guest 7 and the oxygen atom of the closest water molecule.

Journal Article↗

Unusually stable molecular capsule formation of a tetraphenyleneurea cavitand.

An unusually stable molecular capsule was formed by heating phenyleneurea-spanned resorcinarene cavitand with 4-methyl-N-p-tolylbenzamide. The molecular capsule behaved as a discrete molecular entity showing a cylindrical D(4d) structure and showed no guest exchange in toluene-d(8) even at 100 degrees C. [structure: see text]

Journal Article↗

Syntheses, conformations, and basicities of bicyclic triamines.

The multistep syntheses of several bicyclic triamines are described, all of which have an imbedded 1,5,9-triazacyclododecane ring. In 1,5,9-triazabicyclo[7.3.3]pentadecanes 12, 13, 15, and 16, two nitrogens are bridged by three carbons. The monoprotonated forms of these triamines are highly stabilized by a hydrogen-bonded network involving the bridge and both bridgehead nitrogens, producing a difference of more than 8 pK(a) units in acidities of their monoprotonated and diprotonated forms. The one- and zero-carbon bridges in 1,5,9-triazabicyclo[9.1.1]tridecane (23) and 7-methyl-1,5,9-triazabicyclo[5.5.0]dodecane (39) do not enhance the stabilities of their monoprotonated forms. X-ray crystal structures and computational studies of 12.HI and 16.HI reveal similar, but somewhat weaker, hydrogen-bonded networks, relative to 15.HI. The activation free energies for conformational inversion of 13.HI (14.4 +/- 0.2 kcal/mol), 16.HI (15.0 +/- 0.1 kcal/mol) and 16 (8.8 +/- 0.3 kcal/mol) were measured by variable-temperature (1)H and (13)C NMR spectroscopy. These experimental barriers give an estimate of 6.2 kcal/mol for the strength of the bifurcated hydrogen bond between the bridge nitrogen and cavity proton in 16.HI. Computational studies support the hypothesis that N-inversion occurs in an open conformation, leading to an estimate of 10.32 kcal/mol for the enthalpy of the bifurcated hydrogen bond in 16.HI in the gas phase.

Journal Article↗

The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor.

9-Benzyl-3-methylene-1,5-di-p-toluenesulfonyl-1,5,9-triazacyclododecane (CADA) has been identified as a novel antiviral lead compound with significant anti-human immunodeficiency virus and anti-human herpesvirus 7 activity. Surprisingly, this compound selectively decreased the expression of the CD4 glycoprotein, the primary receptor needed for the entry of both viruses. Herein, we describe the CD4 down-modulating and antiviral potencies of more than 25 CADA derivatives. Flow cytometric evaluation of cellular CD4 receptor expression in T cells demonstrated the specific CD4 down-modulating capacity of the CADA derivatives, with IC(50) values similar to those obtained in the antiviral assays. The close correlation observed between the CD4 down-regulating and anti-HIV potencies of the CADA derivatives further points to CD4 receptor down-modulation as the primary mode of antiviral action for this group of compounds.

Anti-HIV Agents↗

Formation of a self-assembled phenylboronic acid monolayer and its application toward developing a surface plasmon resonance-based monosaccharide sensor.

For the surface-optoelectronic study of sugar sensing, we synthesized and characterized dithiobis(4-butyrylamino-m-phenylboronic acid) (DTBA-PBA) as a recognition molecule. DTBA-PBA has a boronic acid group that has been known to form covalently bonded complexes with the 1,2- or 1,3-diol of sugars. A self-assembled monolayer (SAM) of DTBA-PBA was formed on a gold surface and characterized by atomic-force microscopy, Fourier transform infrared reflection absorption spectroscopy, and surface electrochemical measurements. An interaction study between monosaccharides and DTBA-PBA SAM was performed using surface plasmon resonance spectroscopy. The increase in molecular interactions between DTBA-PBA SAM and monosaccharides resulted in an optically induced electron excitation change on the Au surface through a refractive index change of the interfacial recognition layer. This correlation between electron excitation and molecular interaction was measurable at very low monosaccharide concentrations (1.0 x 10(-12)M). DTBA-PBA SAM shows a selective fructose sensing among four kinds of monosaccharides, even in a low concentration range.

Biosensing Techniques↗

CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor.

The novel antiviral agent cyclotriazadisulfonamide (CADA) inhibited human immunodeficiency virus (HIV) (IC50, 0.3-3.2 microM) and human herpesvirus 7 (HHV-7) infection (IC50, 0.3-1.5 microM) in T-cell lines and PBMCs. When T-cells were pretreated with CADA for 24 h, they became markedly protected from viral infection. Flow cytometric analysis revealed a significant decrease in the expression of the CD4 glycoprotein, the primary receptor needed for entry of both viruses. Moreover, the antiviral activity of CADA correlated with its ability to down-modulate the CD4 receptor. CADA did not alter the expression of any other cellular receptor (or HIV coreceptor) examined. Time course experiments showed that CD4 down-modulation by CADA differs in mechanism from the effects of aurintricarboxylic acid, which binds directly to CD4, and phorbol myristate acetate, which activates protein kinase C. Further analysis of CD4 mRNA levels suggested that CADA was not involved in the regulation of CD4 expression at a transcriptional level, but very likely at (post) translational levels. This unique mechanism of action makes CADA an important lead in developing new drugs for treatment of AIDS, autoimmune diseases, and inflammatory disorders.

Anti-Infective Agents↗

Novel C3V-symmetric tripodal scaffold, triethyl cis,cis,cis-2,5,8- tribenzyltrindane-2,5,8-tricarboxylate, for the construction of artificial receptors.

[reaction: see text] A novel C3V-symmetric scaffold, trindane 7, has been efficiently synthesized from 1,3,5-tris(bromomethyl)-2,4,6-tris(chloromethyl)benzene (1) in six steps with 47% overall yield. The control of all-syn stereochemistry in the tribenzylation step has been achieved by blocking one side of the trindane ring as metal carbonyl complexes. The potential utility of trindane 7 as a receptor skeleton has been examined with a urea derivative 12 toward several anionic guests.

Anions↗